Modeling CA-125 During Neoadjuvant Chemotherapy for Predicting Optimal Cytoreduction and Relapse Risk in Ovarian Cancer
- 3 December 2017
- journal article
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 37 (12) , 6879-6886